FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 50, 2014, Pages 17971-17976

  Clatworthy, Menna R ^a   Harford, Sarah K ^b   Mathews, Rebeccah J ^a   Smith, Kenneth G C ^b  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autoimmunity; Fc gamma receptors; Lupus; Lymphangiogenesis; VEGF A

Indexed keywords

CD40 LIGAND; FC RECEPTOR IIB; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; ANTIGEN ANTIBODY COMPLEX; CROSS LINKING REAGENT; FC RECEPTOR; FCGR2B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BINDING AFFINITY; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; GENOTYPE; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; LYMPH NODE; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PROTEIN BLOOD LEVEL; PROTEIN CROSS LINKING; RECEPTOR BINDING; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; ANTAGONISTS AND INHIBITORS; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; EXPERIMENTAL ARTHRITIS; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MACROPHAGE; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULARIZATION;

MURINAE; MUS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CROSS-LINKING REAGENTS; DENDRITIC CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHANGIOGENESIS; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84918562644     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1413915111     Document Type: Article

References (28)

1. Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8(1):34-47.
2. Smith KGC, Clatworthy MR (2010) FcgammaRIIB in autoimmunity and infection: Evolutionary and therapeutic implications. Nat Rev Immunol 10(5):328-343.
3. Floto RA, et al. (2005) Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 11(10):1056-1058.
4. Kono H, et al. (2005) FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 14(19):2881-2892.
5. Willcocks LC, et al. (2010) A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc Natl Acad Sci USA 107(17):7881-7885.
6. Clatworthy MR, Smith KGC (2004) FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 199(5):717-723.
7. Clatworthy MR, et al. (2007) Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA 104(17):7169-7174.
8. Bajénoff M, et al. (2007) Highways, byways and breadcrumbs: Directing lymphocyte traffic in the lymph node. Trends Immunol 28(8):346-352.
9. Randolph GJ, Angeli V, Swartz MA (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5(8):617-628.
10. Angeli V, et al. (2006) B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24(2):203-215.
11. Halin C, Tobler NE, Vigl B, Brown LF, Detmar M (2007) VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110(9):3158-3167.
12. Hirakawa S, et al. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201(7):1089-1099.
13. Shrestha B, et al. (2010) B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. J Immunol 184(9):4819-4826.
14. Chyou S, et al. (2008) Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol 181(6):3887-3896.
15. Kataru RP, et al. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113(22):5650-5659.
16. Haneda Y, et al. (2011) Leukotriene D4 enhances tumor necrosis factor-α-induced vascular endothelial growth factor production in human monocytes/macrophages. Cytokine 55(1):24-28.
17. Brownlie RJ, et al. (2008) Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J Exp Med 205(4):883-895.
18. Phan TG, Green JA, Gray EE, Xu Y, Cyster JG (2009) Immune complex relay by sub-capsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol 10(7):786-793.
19. Junt T, et al. (2007) Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450(7166):110-114.
20. Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275-290.
21. Yilmaz-Elis AS, et al. (2014) FcγRIIb on myeloid cells rather than on B cells protects from collagen-induced arthritis. J Immunol 192(12):5540-5547.
22. Sone H, et al. (2001) Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 281(2):562-568.
23. Watanabe H, et al. (2005) Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model. Clin Cancer Res 11(1):407-409.
24. Kurosaka D, et al. (2010) Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol 37(6):1121-1128.
25. Navarro C, et al. (2002) Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Lupus 11(1):21-24.
26. Siriboonrit U, et al. (2003) Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 61(5):374-383.
27. Lux A, Yu X, Scanlan CN, Nimmerjahn F (2013) Impact of immune complex size and glycosylation on IgG binding to human FcγRs. J Immunol 190(8):4315-4323.
28. Pham TH, et al. (2010) Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med 207(1):17-27.